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Abstract 
Academic scientists are under increasing pressure to engage in more commercially 
“relevant” research, through either patenting and licensing research results, or research 
cooperations. This paper seeks to add to our understanding of academic-business 
collaborations (contract research, joint research, and consulting) by presenting 
preliminary results from a novel survey of academic researchers in the life sciences in 
Denmark. We seek to draw a “profile” of those researchers who cooperate, and why. 
Expressed in a different way, we would like to determine what researcher characteristics 
and competencies business, in practice, demands. Both university and hospital scientists 
were polled. Our most surprising finding is that there is a consistent and highly 
significant relationship between strong publication records and cooperation, across both 
researcher groups, and for all forms of cooperation. Our results underline that it is 
important that scientists be permitted – indeed, encouraged – to continue to operate 
within the norms of the academic community, where success is measured by the 
collegiate reputation-based reward system, thereby maintaining a clear division of labor 
between what scientists do best, and what business does best. 
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1. Introduction1 
 
With the increasing commercialization of innovations in the life sciences, questions about the 
dynamics of academic-business collaborations – and the implications for scientific research, 
the companies, and society – acquire new urgency. Academic scientists are under increasing 
pressure to engage in more commercially “relevant” research, to redirect their work to applied 
projects with more immediate, measurable economic pay-offs. Leading institutions have 
established tech-transfer offices to help their scientists obtain patents and license out the 
rights. Many governments support different forms of knowledge transfer from academic 
institutions to business.  
 
But while we have a reasonably good understanding of why companies collaborate with 
academic researchers (e.g. Berman, 1990, Cohen et al., 2002, Fontana et al., 2006, Monjon 
and Waelbroeck, 2003, Zucker and Darby, 2001), and the dynamics of this process (e.g. 
Breschi et al., 2004, D’Este and Patel, 2005, Colyvas et al., 2002, Feldman et al., 2002, 
Meyer, 2006), much less is known about the academic researchers who cooperate with firms. 
This paper seeks to fill this gap by presenting preliminary results from a novel survey of the 
collaborative activities of academic researchers in the life sciences in Denmark. 
 
There are two main ways to make academic research more relevant to business. One is to 
encourage scientists to patent and license out their research (e.g. Thursby and Thursby, 2002, 
Mowery et al., 2001). Such research must be demonstrably marketable. The other is for 
scientists to cooperate with firms, the focus of this paper. Here, the research does not have to 
be directly marketable, but it must be seen by the company as a valuable input to the 
innovation process.  
 
This paper seeks to draw a “profile” of those researchers who choose to cooperate with 
companies, and why. How important are publication records, research council grants, previous 
                                                 
1 This project is part of a three-year research programme financed by the Danish Social Sciences Research 
Council, Competence, Organisation and Management in Biotech Industries (COMBI), directed by Finn Valentin, 
at the Research Centre on Biotech Business, Copenhagen Business School, whose support we gratefully 
acknowledge. We would also like to thank Keld Laursen for valuable comments on previous drafts of the paper. 
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employment in business, and patent experience? What is the relationship between research 
motivation and cooperation? Expressed in a different way, we would like to determine what 
kinds of researcher characteristics and competencies business, in practice, demands. 
Researchers who cooperate, we assume, are viewed more positively by business than those 
who do not.  
 
 
2. Theoretical background and hypotheses  
 
Scholarship on university-business cooperations is informed by a central “puzzle” (e.g. 
Dasgupta and David, 1994, Liebeskind et al., 1996, McMillan et al., 2000, Merton, 1973). 
University scientists work under a collegiate reputation-based reward system based on the 
norms of open science. Success is tied to priority – coming first in the “race” to publish 
original research in a reputable journal. Due to the nature of scientific research, a scientist’s 
effort cannot easily be observed by external monitors. Publication in refereed journals offers a 
publicly verifiable way for scientists to demonstrate their competencies. Success, for a firm, is 
defined in terms of market performance. Scientific research is (ideally) long-term and 
motivated by curiosity. Corporate research is short-term and motivated by the commercial 
development of research results. While commercial firms are profit-motivated, university 
researchers have a more complex set of objectives, based on a mixture of scholarly, 
educational and societal goals and expectations, not least communicating their results to 
industry (Bercovitz and Feldmann, 2006).  
 
Under the first system, the value of knowledge sharing is emphasized; under the second, the 
appropriability of knowledge. But to what extent is this always – or even necessarily – the 
case? For example, might not scientists, in some circumstances, be more highly motivated to 
enter into joint research with business to be able to engage in cutting edge theoretical research, 
since they can tap directly into corporate budgets (and not rely on shrinking university 
budgets)?  
 
Previous research has documented the importance of academic research in firm innovation 
activities (e.g. Mansfield, 1991, Beise and Stahl, 1999). Firms that have funded university 
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research or cooperated with university researchers in other manners have enjoyed higher rates 
of innovation and performance (e.g. Berman, 1990, Cohen et al., 1998, Monjon and 
Waelbroeck, 2003). Scientists have been a key source of ideas in both the invention and 
innovation process (Cohen et al., 2002a,b, Fontana et al., 2003). Companies benefit 
enormously from the availability of complementary information – in the form of basic 
scientific knowledge – free of charge (Dasgupta and David, 1994). Public science, particularly 
very basic research, is especially important in biotechnology (McMillan et al., 2000). In 
biotechnology, also research collaborations between “star” academic scientists and firm 
scientists have a positive effect on a wide range of performance measures in firms that engage 
in them (Daughterty et al., 2006, Zucker, Darby and Brewer, 1998, Zucker and Darby, 2001). 
Thus it is vital to assess how academic scientists, in practice, contribute to innovation in the 
life sciences.  
 
We start by referencing a discussion in Dasgupta and David (1994), who explore why a young 
scientist would not immediately want to be hired by a firm, at higher pay, to do proprietary 
research. One obvious answer is the benefits of the academic lifestyle. But as Dasgupta and 
David point out, they may have an additional incentive to continue in open science for a while: 
to give them the opportunity to publish their findings, thereby signaling their competencies to 
prospective employers. As researchers grow older, and the costs of deferring the switch to 
business increases, those best at signaling their competencies will move on to an industrial 
career, leading to a gradual ageing of the researchers remaining in the universities. This, the 
authors maintain, is one of the factors that makes the open norm system of academic science 
vulnerable, and there are no economic forces that operate automatically to maintain dynamic 
efficiency between the two systems, and the balance between them. Over the longer term, the 
decline of scientific talent at the universities will negatively affect business as well, reducing 
the quality of public science inputs into their R&D programs. 
 
But Dasgupta and David do not explore academic-business cooperations. In a cooperation, the 
scientist does not move from an academic institution to a company, but remains an academic, 
all the while providing a valuable input to a corporate R&D program. Such collaborations 
would arguably provide a way to reduce the information asymmetries that, according to 
Dasgupta and David, often limit the effectiveness of the university as a scientific information 
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transfer agent. We were interested to investigate how cooperating academic scientists 
successfully operate within the norms of two apparently conflicting systems. We ask: Given 
the differences between academic and industrial research, what distinguishes those researchers 
who cooperate with business from those who do not?  
 
One explanatory factor might be the researcher’s age. We decided to test Dasgupta and 
David’s (1994) underlying assumption that older researchers who remain at academic 
institutions would be of little interest to companies. Had they wished to pursue a career in 
business, they would have done so earlier. Or perhaps the companies did not want to hire 
them. A further argument would be that the older the researcher, the more “socialized” she 
would be into the collegiate-based reward system, and the more resistant to cooperating with 
business. Our prediction is that older researchers will be less likely to cooperate with business. 
 
A second central element in constructing our profile concerns publication activities. Arguably, 
the better the scientist’s publication record, the less likely he would be to cooperate. When 
scientists publish in international journals, their work becomes part of the public domain, 
freely available to all to learn from and build on. Such researchers might be reluctant in 
principle to cooperate with companies, for whom the proprietary control of new knowledge is 
crucial. Similarly, companies looking for research partners might that fear scientists with 
strong publication records would end up “giving away” research results supported by them to 
possible competitors. This reasoning is consistent with Dasgupta and David (1994)’s 
contention that the norms of open science are distinct from the norms of the more “restricted,” 
profit-motivated science practiced by business, with the resultant continuous friction between 
the academic emphasis on publication, and the corporate emphasis on deferring the disclosure 
of new knowledge until ways can be found to appropriate it. 
 
Scientists’ research priorities are reflected in the journals in which they publish. One might 
expect to see a greater incidence of cooperation among scientists who mainly publish in 
journals specializing in applied research than among those who choose journals specializing in 
basic research. Applied research would arguably also be of greater interest to the companies 
concerned, and easier to apply in their R&D programs. The companies might additionally be 
in a better position to evaluate the competencies of scientists in applied fields. 
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What types of professional activities might lead a scientist to collaborate with business? Again 
following the thread of our previous arguments, our prediction is that scientists who cooperate 
would tend to specialize in commercially relevant research. One way to gauge this is whether 
or not the scientist has received a government research council grant, the purpose of which is 
to support basic research. Grant recipients, we reckon, would be less likely to cooperate.  
 
Also important is whether or not the scientist has had actual experience in business. Scientists 
employed in a company prior their current academic position, we predict, will be better 
attuned to the norms and practices of the business world than those who never worked for a 
company. And they might have ready access a strong professional network that would 
facilitate collaboration.  
 
A third possible explanatory factor is previous experiences with patents. In biotechnology, 
patents are essential to commercializing new products and processes (Liebeskind et al., 1996, 
McMillan et al., 2000). Only if the firm possesses the patent rights can it be sure that its 
invention does not infringe an existing patent. Firms typically apply for numerous patents on 
the same basic invention (products, processes, methods, and uses), and may continue to seek 
patent protection on further refinements. This leads to the expectation that scientists who have 
greater understanding of and experience with patenting would be more likely to collaborate 
with business than scientists who lack such experience.  
 
Finally, we wished to investigate the role of research motivation. Scientists strongly motivated 
in their own research by the opportunity to pursue cutting-edge research would arguably be 
less likely to cooperate with companies. Such scientists might well find the commercial 
demands of the industrial R&D lab too restrictive, and/or find it difficult to integrate their 
work into the corporate culture of the R&D lab. Scientists strongly motivated by the 
opportunity to find practical applications for their work would arguably, on the other hand, be 
more likely to cooperate with companies, since it would them to realize their research 
ambitions in practice. They would probably also be more attuned to corporate priorities 
emphasizing the commercialization of research results as quickly as possible.  
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This picture may be captured by the following eight hypotheses: 
 
H1: Younger scientists are more likely to cooperate with business than older ones 
 
H2: Scientists who publish relatively few articles in refereed journals are more likely to 
cooperate with business than scientists who publish relatively many articles 
 
H3: Scientists who mainly publish in journals specializing in applied research are more likely 
to cooperate with business than scientists who mainly publish in journals specializing in basic 
research 
 
H4: Scientists who have not received a grant from the Danish government‘s research council 
are more likely to cooperate with business than scientists who have received a grant 
 
H5: Scientists who have previously worked in a company are more likely to cooperate with 
business than those who have not 
 
H6: Scientists who have been listed as an inventor on a patent application over the past ten 
years are more likely to cooperate with business than scientists who have not  
 
H7: Scientists who are not strongly motivated by the opportunity to pursue cutting-edge basic 
research are more likely to cooperate with business than those who are strongly motivated 
 
H8: Scientists who are strongly motivated to find practical applications for theoretical 
scientific discoveries are more likely to cooperate with business than those who are not 
 
 
3. The empirical data 
 
To test these hypotheses, this paper draws on data collected via an Internet-based 
questionnaire sent to academic researchers in the life sciences in Denmark. The survey was 
conceived by us and carried out by UNI-C, a government institution which performs statistical 
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analyses for university researchers. We defined “life sciences” according to the U.S. National 
Science Foundation, which divides the area into four broad fields: Biological, Environmental 
Biology, Agricultural Sciences, and Medical Sciences.  
 
To define the relevant population, in October 2005, we sent a letter to the heads of all of the 
departments and institutions in Denmark that might have researchers relevant to our inquiry. 
We asked them to specify how many scientists at their institutions should be included. They 
could also decline to participate. In November, 2005, we sent a second letter to the heads of all 
of the institutions who had indicated they wished to participate, containing individual packets 
of information for all the scientists they had informed us were relevant (1744 potential 
respondents in all), and asked them to distribute the packets to these researchers. Each 
researcher was given an access code and a link to an Internet site, where they could log on and 
answer the questionnaire.2 All respondents were guaranteed anonymity, both to us and the 
heads of their institutions.  
 
The data collection closed at the end of January, 2006. In all, 581 responses were received, 
yielding a response rate of 33.3%. 43% of our respondents came from universities, 41% from 
hospitals, and 16% from government research organizations.  
 
As mentioned earlier, the life sciences comprise several disciplines, according to the NSF 
definition. In this particular analysis, we consider only biological and medical sciences 
(excluding observations from agricultural and environmental sciences). We also restrict our 
analysis to researchers in universities and hospitals (excluding observations from government 
research organizations). Finally, we have excluded junior researchers, limiting our sample to 
senior researchers, who we expect would have the best understanding of and experience with 
academic-business collaborations, and who are themselves in control of the collaboration 
                                                 
2 The basic questionnaire consisted of seven main sections: (1) General information about you and your work 
(age, academic degree, position), (2) Your academic research (field of research, publications, grants received, 
research motivation) (3) Academic-business cooperation (nature and frequency of cooperation, motivation to 
cooperate), (4) Role of patents in the life sciences (patenting and licensing activity, motivations to patent and 
license), (5) The technology transfer office (utilization and assessment of TTO); (6) Effects of patenting on 
research on your field (attitudes towards patents), (7) Concluding comments (opportunity for further comments). 
Scientists who answered that they had cooperated with business were asked to answer questions in two additional 
sections: (8) Characteristics of the joint research activity (nature of the cooperation, characteristics of the business 
partner, and if applicable, terms of the contract), (9) Patenting activity in the joint research project (who was 
listed on the application, assessment of the patenting activity). In this paper, we have only analyzed questions 
from Sections 1, 2 and 3. 
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(junior researchers might be pushed into collaborations with senior colleagues). With these 
restrictions, the analyzed sample consists of 264 observations. 
 
 
4. Design of the empirical study 
 
In our statistical model, we apply a simple, linear function and regress a number of variables 
describing the scientist on the three variables capturing the cooperative behaviour we seek to 
analyze. The three types of cooperation are drawn from a section of questions containing a 
total of thirteen different types of cooperation. The ones analyzed here are among the four 
most frequently reported, and they represent three distinctly different types of collaboration. 
Table 1 presents the variables and their summary statistics, not only for the target sample, but 
also for the entire survey sample. 
 
(Table 1 about here) 
 
The table clearly indicates that cooperative behaviour is different in universities and hospitals. 
Hospital scientists frequently do contract research, more than a quarter of them repeatedly. 
They also more frequently consult with companies, but interestingly enough, scientists at 
universities and hospitals engage in the same rate of joint research projects. This suggests that 
hospital scientists possess some immediately useful knowledge or skills, while they are not 
more interesting for companies than their university colleagues when it comes to joint research 
projects. 
 
The independent variables are selected from the survey questions in order to allow for an 
analysis of our eight hypotheses. The set of variables applied in this analysis consists of the 
following: Age, Publications, Publications in basic research journals, Research council 
grants, Prior employment in business, Patent inventor and two motivational variables, The 
opportunity to pursue cutting-edge basic research, and The opportunity to find practical 
applications for basic scientific discoveries. Some deserve a comment.  
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Publications are measured as the (self-reported) number of published articles in refereed 
journals, either as author or co-author, over the past ten years. We used the square root of this 
number to reduce the effect of high values. Publications in basic research journals are 
measured by the percentage of a scientist’s articles published in journals specializing in basic 
research. Research council grants counts the number of grants obtained from a Danish 
government research councils of at least DKK 100,000 (approximately 13,000 euros) over the 
past ten years, registered in three categories: “three times or more”, “once or twice” and “no”. 
Prior employment in business registers if the scientist has over the past ten years been 
employed full-time at least for one year in a private firm. The patent inventor variable registers 
if the scientist has been listed as an inventor on a patent during the past ten years. 
 
Finally, the two motivational variables are drawn from a section of ten factors possibly 
motivating the scientist for doing research in general. Answers are given on a 7-point Likert 
scale from “not at all important” to “very important”. The opportunity to pursue cutting-edge 
basic research has a mean value of 5.6 (7 being “very important”) for senior university 
scientists and 4.9 for hospital scientists. The opportunity to find practical applications for basic 
scientific discoveries has a mean value of 4.9 for university scientists and 5.1 for hospital 
colleagues. As expected, scientists in the two institutions see their role as researchers as 
different. University scientists are clearly more interested in basic scientific discoveries, but it 
should be noted that university researchers show almost same interest in applying these 
discoveries as do their hospital counterparts. 
 
With ordinal dependent variables, an ordered probit regression is the natural choice. Table 2 
reports the results of the same model applied to the three different types of cooperation, and 
run for the three samples: We do this first for all senior university and hospital researchers 
within biological and medical sciences. Then this sample is split into the two subgroups of 
universities and hospitals. In total, nine regressions are shown. The number of observations is 
lower than in Table 1 due to missing answers on the independent variables. 
 
 (Table 2 about here) 
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The model varies considerably in explanatory power. Without over-emphasizing the 
importance of the pseudo-R2, it seems to be better at explaining the behaviour of hospital 
scientists. While not very successful in explaining university scientists’ contract research and 
consulting, it does better in explaining their participation in joint research projects. The reason 
for the former observation probably extends beyond the simple problem of choosing the 
“right” explanatory factors. Most likely, it is a result of a much larger variation in the 
behaviour of university scientist than amongst scientists at hospitals. To establish 
homogeneous samples, we limited the sample to senior scientists working in the same 
scientific fields. This apparently was to some degree possible in hospitals but much less so in 
universities. We suggest that this difference is inherent to the two types of institutions: 
universities probably are much more heterogeneous by nature. As a general note, efforts to 
explain university activities may therefore simply be more demanding. 
 
 
5. Results of the empirical study 
 
As regards the age of the researcher, while we found no significance for university 
researchers, we determined that older hospital scientists were more likely to cooperate with 
business in all of the three forms investigated: contract research (10% significance level), joint 
research (5%) and consulting (5%). A possible explanation is that older researchers have more 
extensive networks, or are more well-known professionally by firms. It also suggests that 
accumulated clinical experience is highly valued by business.  
 
Interestingly, this result contradicts the finding of a previous related empirical study 
(Bercovitz and Feldman, 2003) of scientists from Duke and Johns Hopkins Universities who 
participated in technology transfer activity (admittedly a different focus than our own). They 
determined that “experience years” (the number of years since the last graduate degree was 
obtained) had a negative effect on participation in technology transfer: the probability of a 
researcher disclosing an invention decreased by about 1% for each year since the completion 
of graduate study. 
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Neither hypothesis with regard to publication was confirmed, but for different reasons. As 
regards Hypothesis 2, for university researchers, the more the publications, the more likely 
they were to engage in contract research (5%), joint research (1%), and consulting (10%). For 
hospital researchers, the more likely they were to engage in contract research (1%), joint 
research (1%), and consulting (1%).3 By contrast, the results for Hypothesis 3, across the 
board, are not significant. 
 
Both results are surprising. Even though the number of publications is an (admittedly 
imperfect) measure of the scientist’s skills, it serves as a signal of competence. Perhaps, the 
importance of publications reflects the search activities of companies seeking to identify 
potentially interesting academic partners (Fontana et al., 2006). Companies simply want to 
work with the best. It may indicate a willingness on the part of the companies to support these 
scientists in pursuing their academic publishing objectives. While there is no comparable study 
of this issue in the literature, as far as we can see, it is supported by related studies (Louis et al, 
1989, Etzkowitz, 1983), who found that the individual scientist’s publication rate in refereed 
journals is positively related to entrepreneurial behaviour. 
 
This interpretation is particularly interesting in light of our results for Hypothesis 3. What we 
seem to have uncovered is a marked and significant relationship between strong publication 
records per se and cooperation – but that it does not matter whether the scientist publishes in 
journals specializing in basic or applied research. As regards joint research projects, business 
seems to find university scientists more attractive as partners when they do basic research 
(though not statistically significant). A possible interpretation may concern the nature of 
research in the life sciences, where the boundaries between basic and applied research are 
often blurred (Lehrer and Asakawa, 2004). Alternatively, our results again suggest that 
companies are equally interested in both types of research, depending on the context, but what 
really matters for the choice of academic partner is the academic performance. 
 
                                                 
3 An analysis of the marginal effects of publications on the three dependent variables shows a fundamental 
dichotomy between cooperating at all and not cooperating. The marginal effects of publications on the possibility 
of cooperating “once or twice" is positive in all situations. For universities the effect is approximately of the same 
size as for the "three times or more". The effect of a higher publication rate for university scientists is thus not 
more cooperation, but cooperation at all. However, for hospitals, more publications also predicts more 
cooperation. 
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Our three hypotheses on other professional activities were generally confirmed by the 
tendencies in the data. For Hypothesis 4, only two findings were significant: Hospital 
researchers who received research grants were less likely to engage in contract research (5%), 
and university researchers were less likely to engage in consulting (10%). This may suggest 
that in these two cases, respondents see research grants as an alternative means of financing 
their research. 
 
There was only one significant relationship as regards prior employment in business 
(Hypothesis 5): university researchers were more likely to engage in joint research with 
business (10%). This may indicate that scientists who move from business to academics made 
a deliberate choice, preferring to work within the academic norm system. Yet if they wished, 
they could still draw on their previous business connections to cooperate. However, the 
general lack of significance suggests that prior experience with business cannot substitute 
other factors, such as research performance. 
 
Our expectation for Hypothesis 6 was strongly borne out by the data. University researchers 
listed on patent applications were more likely to engage in contract research (10%), joint 
research (1%), and consulting (10%); hospital researchers so listed were more likely to engage 
in contract research (1%), joint research (1%), and consulting (1%).4 As an important 
methodological precautionary remark, it should be noted that patents are often a direct result 
of either contract research or joint research projects. It might well be that patenting experience 
cannot be taken as a qualifying competence offered to companies ex ante, but a simple result 
of a cooperation. However, even though this problem is not likely for consulting activities, the 
results are rather similar. 
 
Finally, our hypotheses regarding the link between research motivation and cooperation 
produced mixed results. The researcher’s motivation to pursue cutting-edge research and the 
tendency to cooperate with business (Hypothesis 7) was significant in only one way: hospital 
researchers were less likely to engage in consulting (5%). The finding for Hypothesis 7 is 
intriguing. The general lack of significance may suggest that many scientists find that 
                                                 
4 The marginal effects of patenting on cooperation shows perfectly the same patterns as reported above for 
publications. For universities, patenting predicts cooperation (as opposed to no cooperation), while at hospitals, 
patenting leads to more cooperation. 
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cooperating with a firm perhaps does offer them the opportunity to pursue cutting edge 
theoretical research. It suggests that – at least in the life sciences – an expressed interest in 
pursuing cutting-edge basic research does not lead scientists to hide away in their ivory 
towers. Such scientists are as open to collaboration with companies and as attractive to 
companies as their fellow scientists, especially in joint research projects. 
 
Two highly significant results emerged from Hypothesis 8. Hospital scientists who were 
strongly motivated by the opportunity to find practical applications for their research were 
more likely to engage in both contract research (1%) and consulting (1%). This finding 
supports our previous finding (Hypothesis 4) that hospital researchers who received research 
grants were less likely to engage in these forms of cooperation. Together, they suggest that 
hospital scientists may have a strong preference for finding practical applications for their 
research, which they can best realize by performing contract research (and not via support 
from research grants).  
 
Several larger patterns emerge from our data. For both contract research and consulting, it is 
easier to “pin down” the predictors of hospital researchers’ cooperation. The number of 
publications, patent experience, and the opportunity to find practical applications for their 
research are strongly (1% significance) linked to hospital researchers’ tendency to cooperate 
with business. For university researchers, not only are there fewer predictors, but the 
significance is typically lower. 
 
Interestingly, the two groups display a more similar pattern for joint research. In both cases, 
number of publications, and being listed on a patent application, are strong predictors of the 
likelihood of cooperation. For hospitals, age is also a predictor, and for university researchers, 
prior employment in business, but again, at lower levels of significance.  
 
 
6. Discussion and conclusions 
 
Generally speaking, our most important findings concern the very strong links between a 
researcher’s publication record and experience with patents, and the proclivity to cooperate 
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with business. We also found a generally more consistent pattern for hospital scientists than 
for university scientists.  
 
A limitation of this study concerns the basic nature of anonymous questionnaire surveys: there 
is no way to independently verify our results. While we accept that this can be a disadvantage, 
we believe that it is outweighed by the advantage that scientists could answer our questions 
(some of which involved confidential matters) without fear of being identified individually.  
 
Though our work is still preliminary, it is worth speculating as to what some of the 
implications might be. To our knowledge, very few studies have probed whether or not 
university and hospital researchers exhibit different cooperative profiles. An exception is 
Garrett-Jones et al. (2005), who compare the risks and rewards of academic and government 
researchers. While the latter group does not correspond precisely to our category “hospital 
researchers,” they overlap, in that Danish hospital researchers are all publicly employed. 
Garrett-Jones et al. argue that the reward systems and performance measures for university 
researchers are still founded largely on “discovery,” while those for government researchers 
are based upon “application.” This supports the findings of our survey; hospital researchers are 
more focused on applied research than university researchers.  
 
Louis et al. (2001) made a survey of 4,000 clinical and non-clinical life sciences faculty in 
forty nine U.S. research universities. Clinical faculty, they found, were more dependent on 
industry funding, and were more involved in bringing a product to market. Non-clinical 
faculty were more likely to be personally involved in commercializing their research, and 
participating in pre-market commercialization of their research findings. Both groups 
contributed equivalently to the research mission of their universities, as measured by 
publications in peer reviewed journals. This study, too (while based on a slightly different 
sample), supports our findings. 
 
Studies of the relationship between patents and publishing (e.g. Zucker, Darby and Armstrong, 
2002, Zucker and Darby, 2001) have determined that scholars who publish more are also likely 
to patent more. Our analysis has found the same positive relationship between publishing and 
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research collaboration. This apparent strong link between publishing, patenting, and 
cooperation with business could profitably be explored by further research. 
 
Publication in refereed journals is the best indicator we have of high quality research. Our 
study demonstrates that firms, by their choice of academic partner, recognize the value of 
excellent academic records. Many governments, nevertheless, have begun to favor certain 
types of research, channeling research grants into prioritized areas. Our results suggest that 
this is the wrong way to go.  
 
Our conclusion is similar to that drawn by Dasgupta and David (1994) – though for a different 
reason. Dasgupta and David argued that it is vital that universities both create an attractive 
working environment, and compensate their best researchers adequately, so as to keep them, 
as part of the broader effort to maintain the balance between the norms of open science and the 
norms of business. But the two systems, which both reinforce and greatly enrich one another, 
must be kept distinct. Our analysis demonstrates that business itself prefers to cooperate with 
highly reputed academic scholars, whose strong publication records place them squarely 
within the norms of open science.  
 
This study underlines the importance of permitting –indeed encouraging – scientists to 
continue to operate within the norms of the academic community, where success is measured 
by the collegiate reputation-based reward system. Academic and business contributions to 
cooperations must be seen as complementary activities, where each party draws upon, and 
contributes to, the strengths of the other. Scientists must continue to be free to choose their 
areas of research, thereby maintaining a clear division of labor between what scientists do 
best, and what business does best.  
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Table 1 Dependent variables 
  Three times or 
more
Once or 
twice 
No N
You carried out contract research for a firm 
 All respondents 12.1% 20.5% 67.4% 571
 Senior researchers 14.8% 22.9% 62.3% 385
 Senior researchers in biological and medical sciences at universities or hospitals 15.9% 24.2% 59.9% 264
 Senior researchers in biological and medical sciences at universities 6.5% 26.8% 66.7% 138
 Senior researchers in biological and medical sciences at hospitals 26.2% 21.4% 52.4% 126
      
You worked with company researchers within the framework of a cooperative research project 
 All respondents 13.2% 27.7% 59.1% 575
 Senior researchers 17.1% 31.4% 51.6% 386
 Senior researchers in biological and medical sciences at universities or hospitals 18.9% 28.8% 52.3% 264
 Senior researchers in biological and medical sciences at universities 18.8% 29.7% 51.5% 138
 Senior researchers in biological and medical sciences at hospitals 19.1% 27.8% 53.2% 126
      
You served as a consultant to a firm on a private basis 
 All respondents 8.6% 21.7% 69.7% 571
 Senior researchers 11.5% 29.3% 59.2% 382
 Senior researchers in biological and medical sciences at universities or hospitals 14.1% 31.2% 54.8% 263
 Senior researchers in biological and medical sciences at universities 9.5% 33.6% 56.9% 137
 Senior researchers in biological and medical sciences at hospitals 19.1% 28.6% 52.4% 126
 
 19 
 
Table 2: Ordered PROBIT regressions 
Dependent variable Contract research Joint research Consulting 
                            
 All Universities Hospitals All Universities Hospitals All Universities Hospitals 
N 212 110 102 212 110 102 211 109 102 
                            
  Coef. Prob.  Coef. Prob.  Coef. Prob.  Coef. Prob.  Coef. Prob.  Coef. Prob.  Coef. Prob.  Coef. Prob.  Coef. Prob. 
                            
Independent variables                            
* Age + 0,0033 0,740 - 0,0180 0,171 + 0,0331 0,073 + 0,0037 0,707 - 0,0139 0,267 + 0,0394 0,025 + 0,0133 0,179 + 0,0032 0,798 + 0,0361 0,047 
* Publications (sqroot) + 0,1690 0,000 + 0,1282 0,029 + 0,1966 0,000 + 0,1716 0,000 + 0,1604 0,005 + 0,1466 0,005 + 0,1605 0,000 + 0,0997 0,069 + 0,1773 0,001 
* Publications in basic research journals - 0,0037 0,155 - 0,0034 0,395 + 0,0026 0,591 + 0,0036 0,165 + 0,0059 0,127 + 0,0060 0,195 - 0,0003 0,917 + 0,0025 0,510 + 0,0036 0,443 
* Research council grants - 0,2241 0,081 + 0,1695 0,432 - 0,4547 0,014 - 0,1943 0,126 - 0,0843 0,669 + 0,2558 0,147 - 0,0798 0,522 - 0,3819 0,053 + 0,1104 0,516 
* Prior employment in business - 0,0350 0,920 + 0,0524 0,902 + 0,6312 0,390 + 0,3790 0,283 + 0,7112 0,087 - 0,4090 0,587 + 0,1491 0,661 + 0,4370 0,274 - 0,7934 0,317 
* Patent inventor + 0,7341 0,000 + 0,4853 0,074 + 1,6637 0,000 + 0,8122 0,000 + 0,7229 0,006 + 1,2189 0,001 + 0,6305 0,002 + 0,4535 0,086 + 1,1274 0,002 
* Opport. to pursue basic res. - 0,0525 0,367 - 0,1448 0,128 - 0,1250 0,152 + 0,0343 0,551 + 0,0339 0,713 + 0,0135 0,866 - 0,0745 0,196 + 0,0210 0,817 - 0,1866 0,028 
* Opport. to find practical appl. + 0,0799 0,134 - 0,0546 0,482 + 0,2823 0,002 + 0,1019 0,056 + 0,1109 0,156 + 0,0849 0,292 + 0,1711 0,002 + 0,1453 0,060 + 0,2239 0,010 
                            
Pseudo R2   0,12   0,07   0,26   0,14   0,13   0,21   0,12   0,08   0,23 
 
Coloring: 
Significant on a 1% level 
Significant on a 10% level 
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